Popular Articles
Cellulite Cream

NYU Langone Medical Center Awarded NIH Grants Totaling $1,560,000
Two NYU Langone Medical Center researchers have received $1,560,000 in grant support for their first year of studies focused on microbiome and psoriasis and on microbiome and esophageal cancer from the National Institutes of Health (NIH). The studies being conducted at NYU Langone Medical Center are two of several projects being conducted through the NIH Roadmap for Medical Research as part of the Human Microbiome Project (HMP) taking place at institutions across the country.
generic viagra online
Senate Confirms Goosby As U.S. Global AIDS Coordinator
The Senate on Friday confirmed President Obama"s U.S. Global AIDS Coordinator nominee Eric Goosby, the San Francisco Chronicle reports. Goosby - who "served previously in the Clinton administration as director of HIV/AIDS policy in the Department of Health and Human Services and as chief adviser to the president on HIV-related issues" - will now "head the U.S. strategy for addressing HIV around the world, and oversee the implementation of the President"s Emergency Plan for AIDS Relief" (PEPFAR), the newspaper writes. Goosby "has more than 25 years of experience treating HIV/AIDS," and most recently served as chief executive officer and chief medical officer of the Pangaea Global AIDS Foundation, which is affiliated with the San Francisco AIDS Foundation, according to the San Francisco Chronicle (Doyle, San Francisco Chronicle, 6/20).
News of the day
$500,000 Gruber Genetics Prize Awarded To Cancer Geneticist Janet Davison Rowley
Janet Davison Rowley, MD, a founder in the field of cancer cytogenetics and a renowned leader in molecular oncology, will receive the 2009 Genetics Prize of The Peter and Patricia Gruber Foundation. She is being honored with the prestigious international award for discoveries of recurrent chromosomal abnormalities in leukemias and lymphomas - discoveries that have revolutionized how cancer is understood and treated. Currently the Blum-Riese Distinguished Service Professor at the University of Chicago, Rowley is also being honored for her critical national and international leadership in the biomedical research community. The Prize will be presented in Honolulu, Hawaii, on October 23 at the 59th Annual Meeting of the American Society of Human Genetics.
Nutrition

USC Researchers Identify DNA Mutation That Occurs At Beginning Point Of T-Cell Lymphoma

Researchers at the Keck School of Medicine of the University of Southern California (USC) have identified a key mechanism that causes chromosomes within blood cells to break - an occurrence that marks the first step in the development of human lymphoma. The study provides researchers with the clearest insight yet into why these breakages - called chromosomal translocations - occur at a specific points in the chromosome, says principal investigator Michael R. Lieber, M.D., Ph.D., Rita and Edward Polusky Professor in Basic Cancer Research at the Keck School of Medicine. The study appears as the featured cover article in the June 12 issue of the journal Molecular Cell. The study is the second led by Lieber to appear on the cover of a Cell journal in the past six months. "The new findings go to the heart of why cancers begin. This is an opportunity to see the very beginning step of human lymphoma," Lieber says. "With this information, we can now begin to look at ways to interfere with this process in order to stop the lymphoma and to develop more targeted therapies for treatment." There are two types of lymphoma: B cell lymphomas and T cell lymphomas. Both B cells and T cells perform vital functions in the immune system by creating antibodies and destroying virus-infected cells. However, the beginning point, or inception, of most human lymphomas occurs when two chromosomes break and the resulting fragments are reassembled in an exchange. Researchers specifically looked at T cell acute lymphoblastic lymphomas (ALL). ALL accounts for half of all childhood cancers under the age of five, and T cell ALL represents about 10 percent of ALL. The USC scientists identified a specific enzyme known as the RAG complex that occasionally cuts the chromosome at an off-target site, causing lymphocyte (blood) cells to proliferate uncontrollably. They showed that the RAG complex selects the wrong target largely because the proteins in which the wrong chromosome is wrapped (called chromatin) lures the RAG complex to the wrong site. "The immune system is very good at its job," Lieber says. "More than ninety-nine percent of the time it gets it right, but it only takes one mistake in one of a hundred million cells to cause a problem. " The paper follows a similar study, published in the December issue of the journal Cell, in which Lieber and colleagues determined how the most common chromosomal translocation in B cell lymphoma occurs. Researchers at USC have been working for many years to understand the underlying mechanisms that cause blood cancers. "The goal is to understand translocations in various different forms of lymphoma," Lieber says. "The two papers cover more than half of all human lymphomas. That represents a major step forward in understanding this disease." The study was funded by the National Institutes of Health. Noriko Shimazaki, Albert G. Tsai and Michael R. Lieber. "H3K4me3 Stimulates the V(D)J Rag Complex for Both Nicking and Hairpinning in trans in Addition to Tethering in cis: Implications for Translocations." Molecular Cell. June 12, 2009. DOI: 10.1016/j.molcel.2009.05.011. Meghan Lewit University of Southern California


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):